What if prostate cancer could be treated without a single incision, and patients could be home having dinner with their families the very same day?
In this episode, Tom Tamberrino, Chief Commercial Officer of Profound Medical, discusses how the company's MRI-guided TULSA-PRO technology is changing prostate treatment through incisionless, minimally invasive procedures. He explains how focused ultrasound, AI-assisted treatment planning, and real-time MRI guidance enable physicians to treat both prostate cancer and benign prostatic hyperplasia while allowing patients to return home the same day. Tom also explores how new Medicare reimbursement is making the technology financially viable for urology practices, potentially expanding access to MRI-guided care outside traditional hospital settings. He concludes by highlighting the importance of men's health advocacy and introducing LetsHuddle.org, a community designed to encourage open conversations about prostate health and mental well-being.
Tune in to learn how MRI-guided focused ultrasound, AI-assisted treatment planning, and a patient-first approach are redefining prostate care, and why the future of surgery may involve no scalpel at all.
Resources: